Fintel on MSN
UBS Downgrades Owens & Minor (OMI)
Fintel reports that on November 3, 2025, UBS downgraded their outlook for Owens & Minor (NYSE:OMI) from Buy to Neutral.
The market expects Owens & Minor (OMI) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known consensus ...
TipRanks on MSN
Owens & Minor downgraded to Neutral from Buy at UBS
UBS downgraded Owens & Minor to Neutral from Buy with a price target of $4, down from $7. The firm cites the company’s limited earnings visibility ...
In a report released today, Daniel Grosslight from Citi maintained a Buy rating on Owens & Minor (OMI – Research Report). The company’s shares closed yesterday at $16.19. According to TipRanks, ...
San Francisco startup Based Hardware announced during the Consumer Electronics Show in Las Vegas this week the launch of a new AI wearable, Omi, to boost productivity. The device can be worn as a ...
Owens & Minor (NYSE:OMI) has agreed to acquire U.S. home medical equipment provider Rotech Healthcare Holdings (ROTK) for $1.36B in cash. Headquartered in Orlando, Florida, Rotech is a privately held ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback